The Global Sacroiliac Joint Fusion Market, valued at USD 809.8 Million in 2025, is projected to exhibit a CAGR of 13.8%, reaching USD 2,001.6 Million by 2032.
Market expansion is being driven by the rising prevalence of sacroiliac joint dysfunction, degenerative joint disorders, and chronic lower back pain, which are contributing to increased demand for minimally invasive surgical interventions. The growing preference for minimally invasive sacroiliac joint fusion procedures over traditional open surgeries is supporting faster recovery, reduced hospital stays, and improved patient outcomes.
Technological advancements in implant design, navigation systems, and bone graft materials are enhancing procedural efficacy and safety, further driving the market adoption. Additionally, increasing awareness among patients and healthcare providers, coupled with expanding orthopedic infrastructure in emerging economies, is creating significant growth opportunities for key players in the market over the forecast period.
Market Takeaways – Global Sacroiliac Joint Fusion Market
Global Sacroiliac Joint Fusion Market Report Coverage
The full report is now available for purchase: https://www.coherentmi.com/industry-reports/global-sacroiliac-joint-fusion-market
|
Report Coverage |
Details |
|
Market Revenue in 2025 |
USD 809.8 Million |
|
Estimated Value by 2032 |
USD 2,001.6 Million |
|
Growth Rate |
Poised to exhibit a CAGR of 13.8% |
|
Historical Data |
2020-2024 |
|
Forecast Period |
2025–2032 |
|
Forecast Units |
Value (USD Million) |
|
Report Coverage |
Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
|
Segments Covered |
|
|
Geographies Covered |
North America (U.S. and Canada), Latin America (Brazil, Argentina, Mexico, and Rest of Latin America), Europe (Italy, Spain, U.K., Germany, France, Russia, and Rest of Europe), Asia Pacific (China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific), Middle East (GCC Countries, Israel, and Rest of Middle East), and Africa (South Africa, North Africa, and Central Africa) |
|
Growth Drivers |
|
|
Trends |
|
|
Opportunities |
|
|
Restraints & Challenges |
|
Market Dynamics
The global sacroiliac joint fusion market is witnessing strong growth, driven by the increasing prevalence of sacroiliac joint dysfunction, chronic lower back pain, and degenerative joint disorders. Rising awareness of minimally invasive surgical options and their benefits, including reduced surgical trauma, shorter recovery periods, and improved patient outcomes, is significantly boosting adoption across hospitals, ambulatory surgical centers (ASCs), and specialty clinics.
A major driver is technological advancement in sacroiliac joint fusion devices, including minimally invasive implants, navigation-assisted surgical systems, and advanced arthrodesis materials, which are enhancing procedural precision and patient safety. Expanding orthopedic infrastructure, growing investments in spine surgery capabilities, and increasing training for surgeons in advanced techniques further support widespread adoption.
In recent years, the market has seen growing regulatory support for minimally invasive orthopedic procedures, with approvals facilitating faster introduction of novel implants and surgical devices. Additionally, the rising geriatric population and higher incidence of degenerative sacroiliitis are creating consistent demand for surgical intervention.
However, the market faces challenges such as high procedural costs, limited reimbursement coverage in certain regions, and surgical risks associated with fusion procedures. Competition from non-surgical treatments, such as pain management and physical therapy, may also affect adoption rates.
Despite these challenges, the outlook for the sacroiliac joint fusion market remains highly positive. Continuous innovation in device design, expanding hospital and ASC adoption, and increasing awareness of the long-term benefits of surgical intervention are expected to create significant growth opportunities over the forecast period.
Market Trends
There is a strong and accelerating shift toward minimally invasive surgical (MIS) techniques for sacroiliac joint fusion, as patients, providers, and payers increasingly recognize the benefits over traditional open surgeries. MIS procedures reduce incision size, post-operative pain, blood loss, and recovery time, while also lowering hospitalization costs. This has further fueled a rising preference for performing these procedures in ambulatory surgical centers (ASCs) and outpatient facilities, where efficiency and shorter stays are highly valued. Supportive reimbursement policies and regulatory approvals for MIS devices are reinforcing this transition, making minimally invasive and outpatient approaches the standard of care in sacroiliac joint fusion.
In July 2022, the AMA CPT Editorial Panel approved a new Category III code (X034T) for “Arthrodesis, sacroiliac joint, percutaneous, with image guidance, includes placement of intra-articular implant(s)” for minimally invasive SI joint fusion.
Increasing awareness of sacroiliac joint dysfunction and improved diagnostic methods are leading to higher identification and treatment rates of SI-related conditions. As healthcare providers gain a better understanding of differentiating sacroiliac joint pain from other lower back disorders, referrals for fusion procedures are growing.
Additionally, demographic shifts, including aging populations and lifestyle risk factors such as obesity and sedentary habits, are contributing to a larger pool of patients in need of treatment. This trend is supported by expanding reimbursement coverage and regulatory clearances for new devices, further driving demand and making sacroiliac joint fusion a more accessible option for patients worldwide.
Market Opportunities
While the U.S. and Europe remain leading adopters, Asia Pacific and Latin America represent major untapped opportunities due to rapidly aging populations, rising obesity rates, and increasing awareness of musculoskeletal and spinal disorders. Countries like China, India, and Brazil are experiencing growing healthcare investments and improved diagnostic capabilities, which will expand the patient pool. Local partnerships, surgeon training programs, and regulatory approvals in these regions can unlock strong growth potential for global players.
There is a clear opportunity to differentiate in the market through next-generation implant systems (3D-printed titanium, hybrid constructs, porous coatings), biologics/graft substitutes that promote osteointegration, and the integration of robotic-assisted and navigation technologies for precision surgery. As more hospitals adopt digital surgery platforms, companies offering implants compatible with robotic and navigation systems can gain competitive advantage. Moreover, FDA clearances from 2023–2025 (e.g., SI-BONE iFuse Granite, Spinal Simplicity Patriot-SI, Tenon Catamaran expansion) show strong momentum in innovation, suggesting a robust opportunity pipeline.
In October 2023, SurGenTec got FDA clearance for TiLink-P, a novel posterior implant that spans the sacrum and ilium via a 3D-printed titanium implant, using a posterior approach. It combines compression and has NanoTex surface technology and a trellis structure to promote osteointegration.
Analyst View
Recent Key Developments
Competitive Landscape
Global Sacroiliac Joint Fusion Market Segmentation
Regional Insights
Related Reports :